COMPOSITION INCLUDES A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS

The use of fatty acid polyglyceryl esters in cosmetic compositions with thiopyridinone type compounds enhances and accelerates skin penetration, addressing the challenge of skin absorption barriers.

FR3141624B1Active Publication Date: 2024-11-08LOREAL SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
FR2022011482
Authority / Receiving Office
FR · FR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-11-04
Publication Date
2024-11-08
Estimated Expiration
2042-11-04

AI Technical Summary

Technical Problem

Skin care active ingredients face challenges in penetrating through the skin due to its barrier function, necessitating the use of penetration enhancers to improve absorption.

Method used

Combining thiopyridinone type compounds with certain fatty acid polyglyceryl esters in oil-in-water cosmetic compositions enhances and accelerates skin penetration.

Benefits of technology

The combination significantly amplifies and speeds up the penetration of thiopyridinone type compounds, outperforming traditional penetration enhancers.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000040_0000
    Figure 00000040_0000
  • Figure 00000041_0000
    Figure 00000041_0000
  • Figure 00000041_0001
    Figure 00000041_0001
Patent Text Reader

Abstract

Composition comprising a thiopyridinone-type compound and polyglyceryl-based emulsifiers. An oil-in-water cosmetic composition comprising: a thiopyridinone-type compound; one or more fatty acid polyglyceryl esters; an oil phase; and wherein the oil-in-water cosmetic composition is a macroemulsion and the thiopyridinone-type compound penetrates rapidly and in a high quantity. Figure for the abstract: none
Need to check novelty before this filing date? Find Prior Art

Description

Title of the invention: COMPOSITION COMPRISING A THIOPYRIDINONE-TYPE COMPOUND AND POLYGLYCERYL-BASED EMULSIFIERS FIELD OF THE INVENTION

[0001] Cosmetic compositions enhancing the penetration of active ingredients into the skin are provided together with methods of use thereof. BACKGROUND OF THE INVENTION

[0002] There are a wide variety of active ingredients for skin care used in the field of cosmetics and dermatological compositions.

[0003] It is preferable that skin care active ingredients are absorbed by the skin or penetrate into the skin as much as possible. However, skin absorption or skin penetration of such skin care active ingredients is not easy due to the barrier function of the skin. Thus, one possible approach to improve the skin penetration of a skin care active ingredient may be to use a skin penetration enhancer with the skin care active. SUMMARY OF DISCLOSURE

[0004] The present disclosure relates to cosmetic compositions which enhance the penetration of thiopyridinone type compound (I) or (I') into the skin using fatty acid polyglyceryl esters.

[0005] The inventors have discovered that the combination of thiopyridinone compound (I) or (I') with certain fatty acid polyglyceryl esters would enhance the penetration of the thiopyridinone compound and would also contribute to rapid penetration compared to compositions using known penetration enhancers.

[0006] Oil-in-water cosmetic compositions typically include:

[0007] at least one compound selected from the compounds of formula (I) and the tautomer of formula (I') below; and their optical isomers, racemates, and / or solvates such as hydrates, alone or as a mixture: W (H

[0008] Formulas (I) and (I') in which:

[0009] -Ri denotes a radical chosen from:

[0010] a) a hydrogen atom;

[0011] b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from:

[0012] i) -O-R3

[0013] ii)-S-R3;

[0014] - R2 denotes a radical chosen from:

[0015] a) a hydrogen atom;

[0016] b) a linear or branched C3-Ci2 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0017] i) -O-R3

[0018] ii) -S-R3

[0019] iii) -C(O)-O-R3;

[0020] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more Cr-C8 alkoxy radicals;

[0021] c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals

[0022] -R3 denotes a radical chosen from:

[0023] a) a hydrogen atom;

[0024] b) a linear C1-C10 or branched C3-C10 saturated alkyl group;

[0025] one or more polyglyceryl esters of fatty acid;

[0026] one or more oils; and

[0027] wherein the oil-in-water cosmetic composition is a macroemulsion.

[0028] In some embodiments, the penetration of the thiopyridinone compound i) is rapid and enhanced. In various embodiments, the composition enhances the penetration of the thiopyridinone compound i) in an in vitro penetration assay.

[0029] In some embodiments, the thiopyridinone compound i) has a logP value ranging from about -1.5 to about 1.5.

[0030] In some embodiments, the composition is in the form of an oil-in-water macroemulsion. In various embodiments, the penetration of the thiopyridinone compound i) is enhanced through the use of one or more fatty acid polyglyceryl esters. In one or more embodiments, the thiopyridinone compound i) is present from about 0.01 to about 10% by weight, based on the total weight of the cosmetic composition. In some embodiments, the thiopyridinone compound i) is present from about 0.1 to about 5% by weight, based on the total weight of the cosmetic composition. In some embodiments, the thiopyridinone compound i) is present from about 0.5 to about 3% by weight, relative to the total weight of the cosmetic composition.

[0031] In some embodiments, the one or more fatty acid polyglyceryl esters have an HLB of about 8 to about 20. In various embodiments, the fatty acid polyglyceryl esters have a polyglyceryl moiety derived from 2 to 10 glycerins, preferably 2 to 8 glycerins, and more preferably 2 to 6 glycerins. In one or more embodiments, the one or more fatty acid polyglyceryl esters are selected from polyglyceryl monolaurate comprising 2 to 6 glycerol units, polyglyceryl monocaprate comprising 2 to 6 glycerol units, polyglyceryl monooleate comprising 2 to 6 glycerol units, and polyglyceryl distearate comprising 2 to 6 glycerol units.In some embodiments, the one or more polyglyceryl fatty acid esters are selected from the group consisting of polyglyceryl-4 caprate, polyglyceryl-6 dicaprate, polyglyceryl-6 dioleate, polyglyceryl-6 distearate, and mixtures thereof. In one or more embodiments, the one or more polyglyceryl fatty acid esters are present from about 0.5 to about 3% by weight, based on the total weight of the cosmetic composition.

[0032] In some embodiments, the oily phase is present from about 2 to about 25% by weight, relative to the total weight of the cosmetic composition. In various embodiments, the one or more oils are selected from ester oils, hydrocarbon oils, fatty alcohols, fatty ethers, carbonates, silicone oils and mixtures thereof.

[0033] In one or more embodiments, the cosmetic composition may have a pH ranging from about 4.5 to about 6.5, preferably from about 5 to about 6.

[0034] In some embodiments, the oil-in-water cosmetic compositions may include:

[0035] from about 0.01 to about 10% by weight of at least one compound selected from the compounds of formula (I) and the tautomer of formula (!') below; and their optical isomers, racemates, and / or solvates such as hydrates, alone or as a mixture: (U (O

[0036] Formulas (I) and (I') in which:

[0037] -Ri denotes a radical chosen from:

[0038] a) a hydrogen atom;

[0039] b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from:

[0040] i) -O-R3

[0041] ii)-S-R3;

[0042] - R2 denotes a radical chosen from:

[0043] a) a hydrogen atom;

[0044] b) a linear or branched C3-Ci2 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0045] i) -O-R3

[0046] ii) -S-R3

[0047] iii) -C(O)-O-R3;

[0048] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more Cr-C8 alkoxy radicals;

[0049] c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals

[0050] -R3 denotes a radical chosen from:

[0051] a) a hydrogen atom;

[0052] b) a linear C1-C10 or branched C3-C10 saturated alkyl group;

[0053] about 0.5 to about 3% by weight of one or more polyglyceryl fatty acid esters having an HLB of about 8 to about 20;

[0054] one or more oils; and

[0055] wherein the oil-in-water cosmetic composition is a macroemulsion and wherein the penetration of the thiopyridinone compound i) is rapid and amplified.

[0056] The present disclosure relates to methods of using the cosmetic composition, comprising applying the cosmetic composition of the present disclosure to the surface of skin, wherein the cosmetic composition enhances penetration of the thiopyridinone compound into the skin.

[0057] Another aspect of the present disclosure is methods of increasing the percentage of the thiopyridinone compound deposited in the skin, the method comprising topically applying the cosmetic composition of the present disclosure to the skin, wherein the cosmetic composition of the present disclosure increases the percentage of the thiopyridinone compound deposited on the skin.

[0058] These and other aspects of the invention are described in more detail in the description detailed description of the invention.

[0059] The present disclosure describes exemplary embodiments in accordance with the general inventive concepts and is not intended to limit the scope of the invention in any way. Indeed, the invention as described in the specification is broader than and not limited by the exemplary embodiments presented herein, and the terms used herein have their full ordinary meanings. Brief description of the drawings

[0060] [Fig. 1] [Fig. 1] is a graph showing the percentage penetration of the applied thiopyridinone (THP) compound for the Basic and Comparative Formula Examples.

[0061] [Fig.2] [Fig.2] is a graph showing the percentage penetration of the thiopyridinone (THP) compound applied for the Invention and Comparative Examples.

[0062] [Fig.3] [Fig.3] is a graph showing the percentage penetration of nia-cinamide applied for the Basic and Comparative Formula Examples.

[0063] [Fig.4] [Fig.4] is a graph showing the percentage penetration of the thiopyridinone (THP) compound applied for the Invention and Comparative Examples.

[0064] It is understood that the various aspects of the present disclosure are not limited to the arrangements and instruments shown in the figures. DETAILED DESCRIPTION OF THE DISCLOSURE

[0065] The present disclosure relates to cosmetic compositions typically including at least one compound corresponding to the following formula (I) or (T), called “thiopyridinone compound”.

[0066] The present disclosure relates to cosmetic compositions which enhance the penetration of thiopyridinone compounds into the skin using polyglyceryl esters of fatty acids.

[0067] The inventors discovered that the combination of thiopyridinone compound with certain fatty acid polyglyceryl esters would enhance the penetration of the thiopyridinone compound and also contribute to rapid penetration compared to compositions using known penetration enhancers.

[0068] Oil-in-water cosmetic compositions typically include:

[0069] at least one compound selected from the compounds of formula (I) and the tautomer of formula (F) below; and their optical isomers, racemates, and / or solvates such as hydrates, alone or as a mixture: W 01

[0070] Formulas (I) and (I') in which:

[0071] -Ri denotes a radical chosen from:

[0072] a) a hydrogen atom;

[0073] b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from:

[0074] i) -O-R3

[0075] ii)-S-R3;

[0076] - R2 denotes a radical chosen from:

[0077] a) a hydrogen atom;

[0078] b) a linear or branched C3-Ci2 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0079] i) -O-R3

[0080] ii) -S-R3

[0081] iii) -C(O)-O-R3;

[0082] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals;

[0083] c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals

[0084] -R3 denotes a radical chosen from:

[0085] a) a hydrogen atom;

[0086] b) a linear C1-C10 or branched C3-C10 saturated alkyl group;

[0087] one or more polyglyceryl esters of fatty acid;

[0088] one or more oils; and

[0089] Cosmetic formulations comprising thiopyridinone compounds, one or more fatty acid polyglyceryl esters and one or more oils that are suitable for topical application to the skin include compositions in the form of oil-in-water macroemulsions. Thiopyridinone-type compounds

[0090] For the purposes of this disclosure, and unless otherwise indicated:

[0091] a “linear CrCi2 or branched C3-Ci2 saturated hydrocarbon group” is equivalent to a “linear or branched (C1-C12) alkyl group” which corresponds to a linear or branched C1-C12 saturated hydrocarbon group, and preferably a linear or branched C1-C10 hydrocarbon group, more preferably a linear or branched C1-C6 hydrocarbon group; preferably, the linear or branched groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl and decyl.

[0092] More preferably, the linear or branched saturated alkyl groups may be chosen from methyl, ethyl, propyl, isopropyl, butyl, isobutyl and tert-butyl, pentyl, hexyl, heptyl and octyl groups, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl.

[0093] a saturated C3-C8 hydrocarbon cyclic group is a mono- or bicyclic cycloalkyl group containing from 3 to 8 carbon atoms, in particular a monocyclic C5 to C7 cycloalkyl group such as the cyclohexyl group,

[0094] an “alkoxy radical” is an alkyloxy radical for which the alkyl radical is a linear or branched C1-C16 hydrocarbon radical and preferably C1-C8;

[0095] when the alkoxy group is optionally substituted, this implies that the alkyl group is optionally substituted as defined above;

[0096] an “aryl” group represents a carbon-based group, monocyclic or bicyclic, fused or not, comprising from 5 to 12 carbon atoms, preferably from 6 to 10 carbon atoms, and in which at least one cycle is aromatic; preferentially, the aryl radical is a phenyl, biphenyl, naphthyl group, more preferably a phenyl group;

[0097] the term “at least one” is equivalent to the term “one or more”; and

[0098] the term “included” for a concentration range means that the limits of this range are included in the defined range.

[0099] The salts of the compounds of formula (I), (I'), (II) or (II') as defined below include the conventional non-toxic salts of said compounds, such as those formed from an organic or inorganic acid or from an organic or inorganic base.

[0100] As salts of the compounds of formula (I), (I'), (II) or (II'), mention may be made of:

[0101] the salts obtained by adding the compound of formula (I) or (II) to:

[0102] a mineral base, such as sodium hydroxide, potassium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, and sodium, potassium or calcium carbonate or hydrogen carbonate for example;

[0103] or

[0104] an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine. This primary, secondary or tertiary alkylamine tertiary may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functions; mention may be made in particular of 2-amino-2-methylpropanol, ethanolamine, triethanolamine, 2-dimethylaminopropanol, 2-amino-2-(hydroxymethyl)-1,3-propanediol and 3-(dimethylamino)propylamine.

[0105] Mention may also be made of amino acid salts, for example lysine, arginine, guanidine, glutamic acid and aspartic acid. Advantageously, the salts of the compounds of formula (I) or (II) (when they comprise a carboxy group) may be chosen from alkali or alkaline earth metal salts such as sodium, potassium, calcium or magnesium salts and ammonium salts.

[0106] An “organic or inorganic acid salt” is more particularly chosen from the salts chosen from a salt derived from i) hydrochloric acid HCl, ii) hydrobromide acid HBr, iii) sulfuric acid H2SO4, iv) alkylsulfonic acids: Alk-S(O)2OH such as methanesulfonic acid and ethanesulfonic acid; v) arylsulfonic acids: Ar-S(O)2OH such as benzenesulfonic acid and toluenesulfonic acid; vi) citric acid; vii) succinic acid; viii) tartaric acid; ix) lactic acid; x) alkoxysulfinic acids: Alk-OS(O)OH such as methoxysulfinic acid and ethoxysulfinic acid; xi) aryloxysulfinic acids such as tolueneoxysulfinic acid and phenoxysulfinic acid; xii) phosphoric acid H3PO4; xiii) acetic acid CH3C(O)OH; xiv) triflic acid CF3SO3H; and xv) tetrafluoroboric acid HBF4;

[0107] Acceptable solvates of the compounds described in the present disclosure include conventional solvates such as those formed during the preparation of said compounds due to the presence of solvents. Mention may be made, by way of example, of solvates due to the presence of water or linear or branched alcohols, such as ethanol or isopropanol.

[0108] The optical isomers are in particular the enantiomers and the diastereoisomers.

[0109] The compounds used according to the present disclosure therefore correspond to formula (I) or to the tautomer (I') below or to their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in a mixture.

[0110]

[0111] Formulas (I) and (!') in which:

[0112] Ri denotes a radical chosen from:

[0113] a) a hydrogen atom;

[0114] b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from:

[0115] i)-O-R3

[0116] ii)-S-R3;

[0117] R2 denotes a radical chosen from:

[0118] a) a hydrogen atom;

[0119] b) a linear or branched C3-Ci2 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0120] i) -O-R3

[0121] ii) -S-R3

[0122] iii) -C(O)-O-R3;

[0123] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals;

[0124] c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals

[0125] R3 denotes a radical chosen from:

[0126] a) a hydrogen atom;

[0127] b) a linear C1-C10 or branched C3-C10 saturated alkyl group;

[0128] Compound (!') is the tautomeric form of compound (I) when a tau- equilibrium tomeric exists according to the following scheme: (0 (H

[0129] According to one embodiment of the disclosure, Ri represents a hydrogen atom.

[0130] According to another embodiment of the disclosure, Ri represents a linear (C1-C10) alkyl group or a branched (C3-C10) alkyl group, in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably ethyl. In particular, said alkyl group of Ri is not substituted.

[0131] According to one embodiment of the disclosure, R2 represents a hydrogen atom.

[0132] According to another embodiment of the invention, R2 represents an alkyl group (in C1-C10) linear or branched (C3-C10) alkyl group, especially a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, such as a methyl, ethyl, n-pentyl, n-nonyl, isobutyl group, more preferably methyl or ethyl; said alkyl group of R2 being unsubstituted.

[0133] According to another embodiment of the invention, R2 represents a linear (C1-C10) alkyl group or a branched (C3-C10) alkyl group, in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, such as methyl, ethyl, n-pentyl, n-nonyl, isobutyl, more preferably methyl or ethyl; said alkyl group being substituted by one or more groups selected from i), ii), iii) and iv) as defined herein before. Preferably, said alkyl group being substituted by one or two groups selected from i), ii) and iii), more preferably by one or two groups selected from i) and iii), better substituted by a group iii) such as carboxy.

[0134] Another variant for the radical R2 is that said alkyl group is substituted by a group iv) in particular substituted by a phenyl group.

[0135] According to another embodiment of the disclosure, R2 represents a cycloalkyl group (C3-C8), preferably a cycloalkyl group (C5-C7) such as cyclohexyl.

[0136] According to another embodiment of the disclosure, R2 represents a C5-C12 aryl group optionally substituted by one or more hydroxyls and / or by one or more C1-C8 alkoxy radicals, preferably a phenyl group in particular unsubstituted.

[0137] According to one embodiment, R3 represents a hydrogen atom.

[0138] According to another embodiment, R3 represents a linear C1-C10 or branched C3-C10 saturated alkyl group; in particular a linear (C1-C6) alkyl group or a branched (C3-C6) alkyl group, preferably a (C1-C4) alkyl group such as the methyl group.

[0139] Preferably, the compounds of formula (I) and the tautomer (!') or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture, as component A);

[0140] have the following meanings:

[0141] Ri denotes a radical chosen from:

[0142] a) a hydrogen atom;

[0143] b) a linear or branched C1-C6 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from:

[0144] i) -O-R3

[0145] ii)-S-R3;

[0146] preferably optionally substituted by one or more groups i)

[0147] R2 denotes a radical chosen from:

[0148] a) a hydrogen atom;

[0149] b) a linear or branched or cyclic C3-C8 saturated hydrocarbon group such as C5-C6, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0150] i) -O-R3

[0151] ii)-SR-3

[0152] iii) -C(O)-O-R3;

[0153] iv) a phenyl group optionally substituted by one or more hydroxyls and / or by one or more C1-C4 alkoxy radicals such as methoxy;

[0154] preferably substituted by one or more groups selected from i) and iii), preferably iii) such as carboxy

[0155] R3 denotes a radical chosen from:

[0156] a) a hydrogen atom;

[0157] b) a linear C1-C6 or branched C3-C6 saturated alkyl group;

[0158] Preferably, the compounds of formula (I) and the tautomer (!) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture;

[0159] have the following meanings:

[0160] Ri denotes a radical chosen from:

[0161] a) a hydrogen atom;

[0162] b) a linear or branched C1-C4 saturated alkyl group optionally substituted by one or more groups, which may be the same or different, chosen from i) -OR3 more preferably unsubstituted;

[0163] R2 denotes a radical chosen from:

[0164] a) a hydrogen atom;

[0165] b) a linear or branched or cyclic C3-C8 saturated C1-C10 hydrocarbon group such as C5-C6, optionally substituted by one or more groups, which may be identical or different, chosen from:

[0166] i) -O-R3

[0167] iii) -C(O)-O-R3;

[0168] iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more C1-C4 alkoxy radicals;

[0169] R3 denotes a radical chosen from:

[0170] a) a hydrogen atom;

[0171] b) a linear C1-C4 or branched C3-C4 saturated alkyl group such as methyl or ethyl.

[0172] Preferably, the compounds of formula (I) and the tautomer (!) or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or as a mixture;

[0173] have the following meanings:

[0174] Ri is a hydrogen atom; and

[0175] R2 denotes a radical chosen from:

[0176] a) a hydrogen atom;

[0177] b) a linear or branched or cyclic C3-C8 or C3-C5 saturated hydrocarbon group such as C5-C6, substituted by one or more groups, which may be the same or different, chosen from v) -C(O)-O-R3, preferably substituted by a group iii) -C(O)-O-R3;

[0178] R2 is even more preferably a linear C1-C4 or branched C3-C4 saturated hydrocarbon group substituted by a group iii) -C(O)-OR3.

[0179] According to another preferred embodiment, the compounds of formula (I) and the tautomer (!) are selected from the compounds of formula (II) as well as the tautomers thereof, the salts thereof, the solvates thereof and the optical isomers thereof, and the racemates thereof, alone or as a mixture: O ¥ YH xr ¥ o IOJ II 'J ''Nÿ "'S ... > j HO ô (II) (II')

[0180] Formulae (I) and (I') in which R1 and R3 have the same meaning as for the compounds of formula (I) and (I') and X denotes an alkylene radical -(CH2)n- with n being an integer in the range from 1 to 10 inclusive, preferably in the range from 1 to 6, more preferably in the range from 1 to 4, such that 1, preferably R3 represents a hydrogen atom.

[0181] Preferably, the compounds of formula (I), the following compounds are preferably used, and their tautomer or their salts, their optical isomers, racemates, and / or solvates such as hydrates and their derivatives, alone or in mixture: No. Structure Chemical Name CAS No. 1 .a'" h | k’ N-éthyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-75-5 2 ZT""\\ """AA N-méthyl-2-thioxo-1,2 -dihydropyridine-3-car boxamide 91859-74-4 3 '■•V’' . ■> N-octyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-77-7 4 N-benzyl-2-thioxo-1,2 -dihydropyridine-3-car boxamide 91859-79-9 5 / , / \x .■--------\ >■*<------A ’■> / / \\ / \ X / y\ V X\ N-phényl-2-thioxo-1,2 -dihydropyridine-3-car boxamide 104857-16- 1 6 0 :A VV .. U 1 J X’" '■<.■•■" Xff-'' XKZX H 1 H N-cyclohexyl-2-thioxo -1,2-dihydropyridine-3-carboxamide 91859-78-8 7 N-[2-(4-méthoxyphén yl)éthyl]-2-thioxo-l,2-dihydropyridine-3-car boxamide 923682-88- 6 8 ..Ax .,Ax A\ N-(2-méthylpropyl)-2-thioxo-1,2-dihydropyr idine-3-carboxamide 1100027-79 -9 9 H N-pentyl-2-thioxo-1,2 -dihydropyridine-3-carboxamide 330667-57- 7 10 na _ 1 Y ~ "" - N-nonyl-2-thioxo-1,2-dihydropyridine-3-carboxamide 1031149-44 -6 11 XaS z\ h ':ÎK A"X h 'v '"'s H N-(2-hydroxyethyl)-2-thioxo-1,2-dihydropyr idine-3-carboxamide 12 \....... / / > \ / / \ YN,N-diethyl 2-mercaptonicotinami de 13 0 il À 4 ■ CK N-ethyl-N-(2-hydroxy ethyl)-2-thioxo-1,2-di hydropyridine-3-carbo xamide 14 $* / ■'' ,JV .?<. y. A“-^ N-(2,3-dihydroxyprop yl)-2-thioxo-1,2-dihyd ropyridine-3-carboxa mide 15 ■ N-( 1,3-di hydroxyprop an-2-yl)-2-thioxo-1,2-dihydropyridine-3-car boxamide 16 H / Ethyl N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nyl]alaninate 17 r ' -, Ethyl N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nyl]phenyl alaninate 18 rf l-tx !•$ $ £ÿ>t Ethyl N-methyl-N - [(2-thiox o-1,2-dihydropyridin-3-yl)carbonyl]glycinat e 19 Ethyl N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo iiyljglyemate 20 rx <> / < x Q «> x / / O N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo iiyljglyeme 21 f-\ K> JL xo K -¾ H N-methyl-N - [(2-thiox o-1,2-dihydropyridin-3-yl)carbonyl]glycine 22

[0182] Among these compounds, the following compounds are more particularly preferred: No. Structure Chemical Name CAS No. 1 II X XX Y / h 1 : H N-ethyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-75-5 2 X--------YY—Yy / / X / / X- / N-methyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-74-4 4 >3 N-benzyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-79-9 6 Z"" "x...--'' ü H N-cyclohexyl-2-thiox o-1,2-dihydropyridine -3-carboxamide 91859-78-8 7 N- [2- (4-méthoxyphén y l)éthy 1] -2-thioxo-1,2 -dihy dropyridine- 3 -c a rboxamide 923682-88-6 9 c i * N-pentyl-2-thioxo-1,2 -dihy dropyridine- 3 -c a rboxamide 330667-57-7 11 G / ' ( / / / \ # / / < / Zi iL \____ / N-(2-hydroxyéthyl)-2 -thioxo-1,2-dihydropy ridine- 3 -carboxamide 12 i i ? K l H N,N-diéthyl 2-mercaptonicotinami de 14 ss 1, k X ss '><•■"' X / 'XZ N-(2,3-dihydroxyprop yl)-2-thioxo-1,2-dihy dropyridine-3-carboxa mide 15 0 H ■ N-( 1,3-dihydroxyprop an-2-yl)-2-thioxo-1,2-dihydropyridine-3-car boxamide 16 K “ i N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nyl]ethyl alaninate 17 O N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nyl]phenyl ethyl alaninate 18 p: x fd' ...ÀAv N-methyl-N-[(2-thiox o-1,2-dihydropyridin-3-yl)carbonyl]ethyl glycinate 19 y N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nylglycinate ethyl 20 - A > N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nylglycine 21 i....... ,7 \ O N-methyl-N-[(2-thiox o-1,2-dihydropyridin-3-yl)carbonyl]glycine

[0183] More preferably, among these compounds, the following compounds are more particularly preferred: No. Structure Chemical Name CAS No. 1 hh H N-ethyl-2-thioxo-1,2-dihydropyridine-3-car boxamide 91859-75-5 9 ï >1 s N-pentyl-2-thioxo-1,2 -dihy dropyridine- 3 -ca rboxamide 330667-57-7 16 û GW H j' N-[(2-thioxo-1,2-dihy dropyridin-3-yl)carbo nyl]ethyl alaninate 18 O x' v^y-'' CH? Ethyl N-methyl-N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycinate 19 ZX " s H Ethyl N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycinate 20 %___ / s. Z* \ < r Ethyl N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine 21 JZ CH-; QH s?r ^'5 H Ethyl N-methyl-N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine

[0184] Even more preferably, among these compounds, the following compounds are more particularly preferred: No. Structure Chemical Name CAS No. 18 V\ / y ■ ° ÿ s / / / 4 / / \ / / \ J- \= / Ethyl N-methyl-N-[(2-thiox o-1,2-dihydropyridin-3-yl)carbonyl]glycina te 19 il Q Ethyl N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycinate 1 1 - y H 20 V Ethyl N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine 21 G «* H Ethyl N-methyl-N-[(2-thioxo-1,2-dihydropyridin-3-yl)carbonyl]glycine

[0185] In a most preferred embodiment, the compound according to the present disclosure is as follows:

[0186] All compounds can be obtained by a chemical process known to those skilled in the art, from commercially available reagents. We can, for example, use the synthesis process disclosed in European patent application EP3 390 363.

[0187] The composition used according to the disclosure comprises at least one compound of formulas (I) and / or (II) as described above, in a physiologically acceptable medium.

[0188] Compound (I), (I'), (II) and / or (II') may be present in the composition used according to the disclosure in an amount which may be between 0.01% and 10% by weight, preferably between 0.1% and 5% by weight, in particular from 0.5% to 3% by weight, relative to the total weight of the composition.

[0189] A log P value is a value of the base ten logarithm of the apparent octan-l-ol / water partition coefficient. Log p values ​​are known and are determined by a standard test that determines the concentration of compound (c) in octan-l-ol and water. Log P can be calculated according to the method described in the article by Meylan and Howard: Atom / Fragment contribution method for estimating octanol-water partition coefficients, J. Pharm. Sci., 84: 83-92, 1995. This value can also be calculated using many commercially available software packages, which determine log P based on the structure of a molecule. As an example, mention may be made of the Epiwin software of the United States Environmental Protection Agency.

[0190] Values ​​can be calculated using the ACD (Advanced Chemistry Development) Solaris V4.67 software; they can also be obtained from Exploring QSAR: hydrophobicity, electronic and steric constants (ACS professional reference book, 1995). There is also a website that provides estimated values ​​(address: http: / / esc.syrres.com / interkow / kowdemo.htm).

[0191] The composition may also include Vitamin B3 and its derivatives.

[0192] Vitamin B3, also called vitamin PP, is a compound with the following formula:

[0193] in which R may be -CONH2 (niacinamide), -COOH (nicotinic acid or niacin), or CH2OH (nicotinic alcohol), -CO-NH-CH2-COOH (nicotinuric acid) or -CO-NH-OH (niconityl hydroxamic acid).

[0194] Fatty acid depolyglyceryl ester

[0195] The composition according to the present disclosure comprises one or more fatty acid polyglyceryl esters having an HLB value of 8.0 or higher, preferably 8.5 or higher, and more preferably 9.0 or higher. A single type of poly- glyceryl fatty acid ester can be used, but two or more different types of first polyglyceryl fatty acid ester can be used in combination.

[0196] The one or more fatty acid polyglyceryl esters may have an HLB value of 8.0 to 20.0, preferably 8.5 to 18, and more preferably 9.0 to 14.0.

[0197] The term HLB (“hydrophilic-lipophilic balance”) is well known to those skilled in the art and reflects the ratio between the hydrophilic part and the lipophilic part in the molecule.

[0198] The one or more polyglyceryl esters of fatty acid may be chosen from mono, di, tri esters and higher esters of saturated or unsaturated fatty acid(s).

[0199] It is preferable that the one or more fatty acid polyglyceryl esters comprise 2 to 4 glycerol units, preferably 3 or 4 glycerol units, and more preferably 4 glycerol units.

[0200] The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise 12 or fewer carbon atoms, preferably 11 or fewer carbon atoms, and more preferably 10 or fewer carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise 4 or more carbon atoms, preferably 6 or more carbon atoms, and more preferably 8 or more carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise 4 to 12, preferably 6 to 11, and more preferably 8 to 10 carbon atoms.

[0201] The fatty acid for the fatty acid moiety of the one or more fatty acid polyglyceryl esters may be saturated or unsaturated, and may be selected from caprylic acid, capric acid, and lauric acid.

[0202] The one or more fatty acid polyglyceryl ester(s) may be selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: 14), PG4 laurate (HLB: about 14), PG4 caprate (HLB: 14), PG5 myristate (HLB: 15.4), PG5 stearate (HLB: 15), PG-5 oleate (HLB 11.5), PG6 caprylate (HLB: 14.6), PG6 caprate (HLB: 13.1), PG6 laurate (HLB: 14.1), PG 10 laurate (HLB: 15.2), PG 10 myristate (HLB: 14.9), PG10 stearate (HLB: 14.1), PG10 isostearate (HLB: 13.7), PG-10 diisostearate (HLB: 11), PG10 oleate (HLB: 13.0), PG10 cocoate (HLB: 16), and mixtures thereof.

[0203] It may be preferable that the one or more fatty acid polyglyceryl ester(s) are selected from the group consisting of PG3 caprate (HLB: about 14), PG4 caprylate (HLB: about 14), PG4 laurate (HLB: about 14), PG4 caprate PG4 (HLB: 14), and mixtures thereof.

[0204] The one or more polyglyceryl esters of fatty acid may be chosen from mono, di, tri esters and higher esters of saturated or unsaturated fatty acid(s).

[0205] The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise 14 or more carbon atoms, preferably 16 or more carbon atoms, and more preferably 18 or more carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise 30 or fewer carbon atoms, preferably 24 or fewer carbon atoms, and more preferably 20 or fewer carbon atoms. The fatty acid for the fatty acid moiety or the fatty acid moiety of the one or more polyglyceryl esters of fatty acids may comprise from 14 to 30, preferably from 16 to 24, and more preferably from 18 to 20 carbon atoms.

[0206] The fatty acid for the fatty acid moiety of the one or more fatty acid polyglyceryl esters may be saturated or unsaturated, and may be selected from myristic acid, stearic acid, isostearic acid, and oleic acid.

[0207] The one or more fatty acid polyglyceryl ester(s) may be selected from the group consisting of PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopahnitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), PG6 distearate (HLB: 8), PG10 distearate (HLB: about 9), PG10 tristearate (HLB: 8), PG10 dii-sostearate (HLB: 10), PG10 triisostearate (HLB: 8), PG 10 tricocoate (HLB: 9), and mixtures thereof.

[0208] It may be preferable that the one or more fatty acid polyglyceryl esters are selected from the group consisting of PG2 isostearate (HLB: 8), PG2 oleate (HLB: 8), PG2 sesquicaprylate (HLB: about 8), PG2 caprate (HLB: 9.5), PG2 laurate (HLB: 8.5), PG2 myristate (HLB: 10), PG2 isopahnitate (HLB: 9), PG4 oleate (HLB: 10), PG4 stearate (HLB: 9), PG4 isostearate (HLB: 8.2), and mixtures thereof.

[0209] Examples of the one or more fatty acid polyglyceryl esters include SunSoft® Q-17D(G) from Taiyo Kagaku Co., Ltd., SunSoft® A-121E-C from Taiyo Kagaku Co., Ltd., and Tegosoft® PC 41 from Evonik Co., Ltd.

[0210] The amount of the one or more fatty acid polyglyceryl ester(s) in the composition according to the present disclosure may be from about 0.5 to about 3% by weight relative to the total weight of the cosmetic composition.

[0211] The total of the one or more fatty acid polyglyceryl ester(s) in the composition is typically in an amount of about 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.2, 1.4, 1.5 to about 1.5, 1.6, 1.8, 2.0, 2.2, 2.4, 2.6, 2.8 or 3.0% by weight, based on the total weight of the composition.

[0212] Emulsifiers

[0213] In some embodiments, the cosmetic composition may include one or more emulsifiers. Oils)

[0214] Cosmetic compositions include an oily phase comprising one or more oils. The amount of oily phase (e.g., the total amount of oils) is typically from 0.5 to 40% by weight, based on the total weight of the cosmetic composition. In some cases, the cosmetic composition includes oils that are plant-based or vegetable oils.

[0215] The amount of oils present in the cosmetic composition may be from about 0.5 to about 40% by weight, from about 0.5 to about 38% by weight, from about 0.5 to about 34% by weight, from about 0.5 to about 32% by weight; 0.5 to about 30% by weight, 0.5 to about 28% by weight, 0.5 to about 26% by weight, 0.5 to about 24% by weight, about 1 to about 40% by weight, 1 to about 38% by weight, 1 to about 36% by weight, 1 to about 34% by weight, 1 to about 32% by weight, 1 to about 30% by weight, 1 to about 28% by weight, 1 to about 26% by weight, 1 to about 24% by weight, about 2 to about 40% by weight, 2 to about 38% by weight, 2 to about 36% by weight, 2 to about 34% by weight, 2 to about 32% by weight, 2 to about 30% by weight, 2 to about 28% by weight, 2 to about 26% by weight, 2 about 24% by weight, about 3 to about 40% by weight, about 3 to about 38% by weight, about 3 to about 36% by weight, about 3 to about 34% by weight,about 3 to about 32 wt%, about 3 to about 30 wt%, about 3 to about 28 wt%, about 3 to about 26 wt%, about 3 to about 24 wt%, about 4 to about 40 wt%, about 3 to about 38 wt%, about 4 to about 36 wt%, about 4 to about 34 wt%, about 4 to about 32 wt%, about 4 to about 30 wt%, about 4 to about 28 wt%, about 4 to about 26 wt%, about 5 to about 40 wt%, about 5 to about 38 wt%, about 5 to about 36 wt%, about 5 to about 34 wt%, about 5 to about 32 wt%, about 5 to about 32 wt%, about 5 to about 30 wt%, about 5 at about 28% by weight, about 5 to about 26% by weight, or about 5 to about 24% by weight, including all intermediate ranges and sub-ranges, based on the total weight of the cosmetic composition.

[0216] Additionally and / or alternatively, the cosmetic composition may exclude synthetic oils. In some cases, the cosmetic composition may exclude oils other than plant and vegetable based oils. For example, the amount of synthetic oils and / or oils other than plant and vegetable based oils may be of about 5% by weight or less, about 4% by weight or less, about 3% by weight or less, about 2% by weight or less, about 1% by weight or less, or about 0.5% by weight or less, based on the total weight of the cosmetic composition. In at least one embodiment, the cosmetic composition is free or essentially free of synthetic oils and / or oils other than plant and vegetable based oils.

[0217] The term "oil" refers to any fatty substance that is in liquid form at room temperature (20-25°C) and atmospheric pressure (760 mmHg). Often, at least one of the oils in the cosmetic composition is part of an oil phase. An "oil phase" is a phase comprising at least one oil that may include additional liposoluble and lipophilic ingredients and the fatty substances. An oil suitable for the present use may be volatile or non-volatile. The term "volatile oil" refers to an oil that is capable of evaporating upon contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure. Volatile oil(s) is (are) liquid at room temperature and has (have) a non-zero vapor pressure, at room temperature and atmospheric pressure, in particular in the range of 0.13 Pa to 40,000 Pa (103 to 300 mmHg).The term "non-volatile oil" means an oil which remains on the skin or keratinous fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 103 mmHg (0.13 Pa). pH correction agent

[0218] The composition according to the present invention may comprise at least one pH correcting agent (pH corrector). Two or more pH correcting agents may be used in combination. Thus, a single type of pH correcting agent or a combination of different types of pH correcting agents may be used.

[0219] As pH correction agent, at least one acidifying agent and / or at least one basifying agent (alkaline agent) may be used.

[0220] The acidifying agent may be a monovalent or polyvalent acid, such as divalent.

[0221] The acidifying agents may be, for example, mineral (inorganic) acids such as hydrochloric acid, sulfuric acid, phosphoric acid, or organic acids such as carboxylic acids, for example tartaric acid, citric acid and lactic acid, as well as sulfonic acids.

[0222] The basifying agent may be a monovalent or polyvalent base, such as divalent.

[0223] Basifying agents can be mineral (inorganic) or organic, or hybrid.

[0224] The mineral basifying agents may be chosen from aqueous ammonia; alkali metal carbonates or bicarbonates such as sodium or potassium and sodium or potassium bicarbonates; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; and mixtures thereof.

[0225] The organic basifying agents may be chosen from organic amines whose pKb at 25°C is less than 12, preferably less than 10, and even more advantageously less than 6. It should be noted that this is the pKb corresponding to the function of greatest basicity. In addition, the organic amines do not comprise any alkyl or alkenyl fatty chain comprising more than ten carbon atoms.

[0226] The organic basifying agent may be chosen, for example, from alkanolamines, oxyethylenated and / or oxypropylenated ethylenediamines, amino acids and amine compounds of formula (III) below:

[0227] in which

[0228] W represents a divalent C1-C6 alkylene radical optionally substituted by one or more hydroxyl groups or a C1-C6 alkyl radical, and optionally interrupted by one or more heteroatoms such as O and N, and

[0229] Rx, Ry, Rz and Rt, which may be the same or different, represent a hydrogen atom or a C1-C6 alkyl, C1-C6 hydroxyalkyl, or C1-C6 aminoalkyl radical.

[0230] Examples of amine compounds of formula (III) which may be mentioned include 1,3-diaminopropane, 1,3-diamino-2-propanol, spermine and spermidine.

[0231] The term “alkanolamine” designates an organic amine comprising a primary, secondary or tertiary amine function, and one or more linear or branched CrC8 alkyl groups carrying one or more hydroxyl radicals.

[0232] Alkanolamines such as monoalkanolamines, dialkanolamines or trialkanolamines comprising one to three identical or different C1-C4 hydroxyalkyl radicals may be suitable for the present invention. Among the compounds of this type, mention may be made of monoethanolamine (MEA), diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, N-dimethylaminoethanolamine, 2-amino-2-methyl-l-propanol, triisopropanolamine, 2-amino-2-methyl-l,3-propanediol, 3-amino-l,2-propanediol, 3-dimethylamino-l,2-propanediol and tris(hydroxymethylamino)methane.

[0233] The amino acids which can be used are of natural or synthetic origin, in their L, D or racemic form, and comprise at least one acid function chosen more particularly from the carboxylic acid, sulfonic acid, phosphonic acid or phosphoric acid functions. The amino acids can be in neutral or ionic form.

[0234] As amino acids which may be used in the present invention, mention may be made in particular of aspartic acid, glutamic acid, alanine, arginine, omithine, citrulline, asparagine, carnitine, cysteine, glutamine, glycine, histidine, lysine, isoleucine, leucine, methionine, N-phenylalanine, proline, serine, taurine, threonine, tryptophan, tyrosine and valine.

[0235] It may be preferable that the amino acids are basic amino acids comprising an additional amine function optionally included in a cycle or in a ureido function.

[0236] Such basic amino acids may preferably be chosen from those corresponding to formula (IV) below: NH„ <IV) / & "—CH\

[0237] in which

[0238] R represents a group chosen from: V / /

[0239] -(CH2)3-NH2,

[0240] -(CH2)2-NH2,

[0241] -(CH2)2-NH-CO-NH2, and

[0242] Compounds corresponding to formula (IV) include histidine, lysine, arginine, ornithine and citrulline.

[0243] The organic basifying agent may be chosen from organic amines of heterocyclic type. In addition to histidine, which has already been mentioned in the amino acids, mention may in particular be made of pyridine, piperidine, imidazole, triazole, tetrazole and benzimidazole.

[0244] The organic basifying agent may also be chosen from amino acid dipeptides. As amino acid dipeptides which may be used in the present invention, mention may in particular be made of carnosine, anserine and balein.

[0245] The organic basifying agent may also be chosen from compounds comprising a guanidine function. As amines of this type which may be used in the present invention, in addition to arginine, which has already been mentioned as an amino acid, mention may in particular be made of creatine, creatinine, 1,1-dimethylguanidine, 1,1-diethylguanidine, glycocyamine, metformin, agmatine, N-amidinoalanine, 3-guanidinopropionic acid, 4-guanidinobutyric acid and 2-([amino(imino)methyl]amino)ethane-1-sulfonic acid.

[0246] In a preferred embodiment of the present invention, the organic basifying agent may be selected from amino acids, preferably basic amino acids, and more preferably arginine, lysine, histidine or mixtures thereof. Even more preferably, the organic basifying agent may be arginine.

[0247] Hybrid compounds that may be mentioned include salts of the aforementioned amines with acids such as carbonic acid or hydrochloric acid. Guanidine carbonate or monoethanolamine hydrochloride may in particular be used.

[0248] The pH correcting agent may be present in an amount of 0.01% by weight or more, preferably 0.05% by weight or more, and more preferably 0.1% by weight or more, based on the total weight of the composition.

[0249] The pH correcting agent may be present in an amount of 15% by weight or less, preferably 10% by weight or less, and more preferably 5% by weight or less, based on the total weight of the composition.

[0250] The pH correcting agent may be present in an amount ranging from 0.01% to 15% by weight, preferably from 0.05% to 10% by weight and more preferably from 0.1% to 5% by weight or less, based on the total weight of the composition.

[0251] It is preferable that the composition according to the present invention has a pH of 4.5 or higher, and more preferably 5 or higher.

[0252] It is preferable that the composition according to the present invention has a pH of 6.5 or less and, more preferably, 6 or less.

[0253] It is preferable that the composition according to the present invention has a pH of 4.5 to 6.5 and, more preferably, of 5 to 6.

[0254] The pH of the composition means the pH of the aqueous phase of the composition according to the present invention.

[0255] It may be preferable that at least one buffer or buffering agent is also used, as a pH correcting agent, in combination with the acidifying agent and / or the basifying agent, in order to stabilize the pH of the composition according to the present invention.

[0256] As the buffer, any of the commonly known buffers may be used. For example, salts of acids or bases, preferably salts of weak acids or weak bases, may be used. For example, sodium citrate or sodium lactate may be used as the buffer, if citric acid or lactic acid is used as the acidifying agent. Cosmetically acceptable carrier system

[0257] The cosmetic compositions include a cosmetically acceptable carrier system. The term "cosmetically acceptable" means a carrier that is compatible with any keratinous substrate, and for this purpose, includes water and optionally water-based solvents except as otherwise disclosed herein.

[0258] The cosmetic compositions may comprise any constituent normally employed in the intended topical application and administration. Particular mention may be made of water, solvents, polyols, fatty compounds (i.e., as described by the International Federation of Cosmetic Chemistry Societies, for example, in Cosmetic Raw Material Analysis and Quality Volume I: Hydrocarbons, Glycerides, Waxes and Other Esters (Redwood Books, 1994)), pigments, fillers, silicones, surfactants, thickeners, gelling agents, preservatives, and mixtures thereof in any proportions. Shape

[0259] The composition according to the present disclosure is in the form of a macroemulsion.

[0260] Macroemulsions are thermodynamically unstable, dispersed liquid-liquid systems with particle sizes in the range of 1 to 100 qm (orders of magnitude), which most often do not form spontaneously. Macroemulsions scatter light efficiently and therefore have a milky appearance, because their droplets are larger than a wavelength of light.[l] They are part of a larger family of emulsions together with miniemulsions (or nanoemulsions). As with all emulsions, one phase serves as the dispersing agent. This is often referred to as the continuous or external phase. The remaining phase(s) is (are) a dispersed or internal phase(s), because the liquid droplets are finely distributed between the larger continuous phase droplets.[2] This type of emulsion is thermodynamically unstable, but can be stabilized for a period of time with the applications of kinetic energy.[1] Surfactants (as the main emulsifiers) are used to reduce the interfacial tension between the two phases and induce macroemulsion stability for a useful period of time. Emulsions can be stabilized by . elsewhere with polymers, solid particles (stripping emulsions) or proteins.

[0261] The macroemulsion may have a dispersed phase having a particle size of not less than 600 nm in total at a minimum. Most likely in a micron range, such as 0.8 to 20 microns. They do not form spontaneously (as microemulsions do).

[0262] The O / W architecture or structure, which consists of oily phases dispersed in an aqueous phase, has an external aqueous phase, and therefore if the composition according to the present disclosure has the O / W architecture or structure, it can provide a pleasant sensation during use due to the immediate cooling sensation that the aqueous phase can provide.

[0263] The particle size can be measured by a dynamic light scattering method. The particle size measurement can be performed, for example, by the ELSZ-2000 series of particle size analyzers, marketed by Otsuka Electronics Co., Ltd.

[0264] The particle size may be a volume average particle diameter or a number average particle diameter, preferably a volume average particle diameter. Methods of use

[0265] The present disclosure also relates to methods of using the cosmetic compositions described herein. For example, the cosmetic compositions may be used in a method that comprises applying the cosmetic compositions to human skin. In some cases, the composition is applied to the face. Furthermore, the cosmetic composition may be used in methods of depigmenting, lightening and / or bleaching keratin materials, preferably the skin, comprising the step of: applying to the keratin substance the composition according to the compositions described herein. The methods mentioned above are non-therapeutic.

[0266] The cosmetic composition may be applied once a day, twice a day, or more than once or twice a day. In some cases, the composition is applied in the evening before bedtime. In other cases, the compositions are applied in the morning. In still other cases, the composition may be applied immediately after washing the skin. The compositions may be used once, or for a series of days, weeks, or months. For example, the compositions may be used daily for a period of 1, 2, 3, 4, 5, 6, 7, 8 or more weeks, or months.

[0267] The present disclosure also relates to a non-therapeutic cosmetic process- Method for depigmenting, lightening and / or bleaching keratin materials, preferably the skin, comprising the step of applying to the keratin substance the composition according to the compositions described in this document.

[0268] Another aspect of the present disclosure relates to a use of:

[0269] One or more polyglyceryl esters of fatty acid;

[0270] to amplify or improve the penetration into the skin of

[0271] thiopyridinone type compound;

[0272] in a composition in the form of a macroemulsion comprising:

[0273] One or more oils. EXAMPLES

[0274] An implementation of the present disclosure is provided by means of the following examples. The following examples serve to explain certain aspects of the technology without being limiting in nature. Example 1

[0275] Example 1: Synthesis of compound 20

[0276] Compound 20 is synthesized as disclosed in Example 2 of patent EP3 390 363. Example 2

[0277] (Compositions of the invention)

[0278] The following compositions according to Inventive Examples 1 to 3, Basic Formula and Comparative Examples 1 to 4 shown in Table 1 and 2, were prepared using the following general procedure.

[0279] Generally, water-soluble raw materials (minus active ingredients) were added to the main tank and dissolved. Polymers were then added and mixed until well dispersed. The batch was heated to 75°C. In a side tank, the fatty compounds, silicones, and emulsifiers / surfactants were mixed together and heated to 75°C. The side tank was added to the main tank while thoroughly homogenizing. When well emulsified, the batch was cooled to room temperature, and active ingredients and fillers were added.

[0280] [Table 1] Inventive compositions INCI US Inventive Ex. 1 Inventive Ex. 2 Inventive Ex. 3 a compound of Thiopyridinone type (THP) 0.50 0.50 0.50 Niacinamide 10.00 10.00 10.00 b Polyglyceryl-4 Caprate 1.62 1.62 1.62 Emulsifiers 2.5 3.5 3.61 c Oils 12.3 12.4 12.4 Polymer 1.37 1.37 1.37 Filler 0.40 0.40 0.40 Chelating Agent 0.11 0.11 0.11 Active Compound 1.40 1.40 1.40 Vitamin 0.25 0.25 0.25 pH Adjuster, Preservative 1.50 1.50 1.50 Water-soluble solvents 11.21 11.21 11.23 Water QSQSQS

[0281] [Table 2] Comparative compositions INCI US Basic formula Ex. comp. 1 Ex. comp. 2 Ex. comp. 3 Ex. comp. 4 compound of Thi-pyridinone type (THP) 0.50 0.50 0.50 0.50 0.50 Niacinamide 10.00 10.00 10.00 10.00 10.00 Emulsifiers 2.5 2.5 2.5 2.61 4.3 Oils 12.3 12.3 12.3 12.3 12.3 Polymer Polymers 1.37 1.37 1.37 1.37 1.37 Filler 0.40 0.40 0.40 0.40 chelating agent 0.11 0.11 0.11 0.11 0.11 active compound active compound 1.40 1.40 1.40 1.40 1.40 vitamin vitamin 0.25 0.25 0.25 0.25 0.25 Water soluble solvent Water soluble solvent 11.21 11.21 14.21 11.23 11.21 pH adjuster pH adjuster 1.5 1.5 1.5 1.5 1.5 solvent Water QSQSQSQSQS Example 3

[0282] Inventive Examples and Comparative Examples were tested to measure the enhanced penetration of the active ingredients. The enhanced penetration of the Inventive and Comparative Examples was evaluated by following the procedure described below.

[0283] The penetration test experiments were carried out in a Franz diffusion cell (Hanson) with a Strat-M membrane (Millipore, 15 mm diameter). This equipment consisted of a donor part and a receiver part, with the Strat-M membrane being sandwiched between the donor and receiver parts. The receiver part of a predetermined volume was filled with a receiver solution (0.25 wt% Tween 80 / deionized water) maintained at a temperature of 32°C, which was continuously stirred with a small magnetic bar. Each of the compositions according to Examples 1-3 and Comparative Examples 1-4 was spread with a spatula on the membrane of the donor part with an amount of 30 mg / cm2. After 5 hours, 200 μl of receptor solution was removed from the receptor part, while supplying the same amount of a new receptor solution to the receptor part to maintain the same penetration conditions.The withdrawn receptor solution was analyzed by HPLC to determine the amount of active ingredient in the receptor solution. The percentage of active ingredient that crossed the membrane was calculated by dividing the detected amount of active ingredient in the receptor solution by the amount of active ingredient spread on the membrane. The amount of active ingredient in the cell was then plotted against time to determine the rate of diffusion across the membrane, as well as the total amount diffused after 24 hours.

[0284] The aim of the study was to show that the fatty acid polyglyceryl ester was capable of amplifying the penetration of active ingredients in a traditional oil-in-water macroemulsion.

[0285] Several penetration enhancers have been studied (i.e. ethoxydiglycol, dimethyl isosorbide, dilauramidoglutamide sodium lysine as well as other raw materials which are not known to be penetration enhancers (namely laureth-4 and polyglyceryl-4 caprate).

[0286] The results are shown in [Fig.l], 2, 3 and 4.

[0287] [Fig.l] and [Fig.2] represented the percentage of penetration of the thiopyridinone compound (i.e., THP) through the membrane over time.

[0288] The Base Formula began to penetrate through the membrane within 1 hour and continued to increase over time until reaching a plateau after 24 hours. The Base Formula did not contain a polyglyceryl ester of fatty acid having an HLB of about 8 to about 20.

[0289] Ex. comp. 1 and Ex. comp. 2 showed that the penetration of THP was slow also at the beginning. In the case of Ex. comp. 2, it was even observed that the penetration of the thiopyridinone compound was very limited in time. In the case of Ex. comp. 1, the penetration increased slowly and also reached a plateau, but however it did not reach the high level reached with the basic formula. Both Comparative Examples did not contain a fatty acid polyglyceryl ester having an HLB of about 8 to about 20.

[0290] Comparative Ex. 4 showed a similar profile to Comparative Ex. 2. Penetration of the thiopyridinun compound was slow and very limited. In the case of Comparative Ex. 3, penetration was higher at first and then reached a plateau. Both Comparative Examples did not contain a polyglyceryl ester of fatty acid having an HLB of about 8 to about 20.

[0291] However, inventive Ex. 1 showed that the penetration of the thiopyridinone compound was at about 78% at the beginning which was much higher than for any of the comp. Ex. Thereafter, the penetration continued to increase and was above 80% after only a few hours. The penetration level was stable after 24 hours. The inventive example proved that the presence of a fatty acid polyglyceryl ester having an HLB of about 8 to about 20 not only increased the penetration level of the active ingredient, but surprisingly, did so almost immediately after the products were applied to the membrane.

[0292] These experiments surprisingly showed that the use of at least one fatty acid polyglyceryl ester influences the rate of penetration of an active ingredient through the membrane but simultaneously increased the % penetration through the membrane.

[0293] [Fig.3] and [Fig.4] represented the percentage of Nia-cinamide penetration through the membrane over time.

[0294] The Base Formula began to penetrate through the membrane within 1 hour and continued to increase over time until reaching a plateau after 24 hours. The Base Formula did not contain a polyglyceryl ester of fatty acid having an HLB of about 8 to about 20.

[0295] Comparative Ex. 1 and Comparative Ex. 2 showed that the penetration of Niacinamide was slow also at the beginning. In the case of Comparative Ex. 2, it was even observed that the penetration of THP was very limited in time. In the case of Comparative Ex. 1, the penetration increased slowly and also reached a plateau, but however it did not reach the high level achieved with the basic formula. None of the Comparative Examples contained a polyglyceryl ester of fatty acid having an HLB of about 8 to about 20.

[0296] Comparative Ex. 4 showed a similar profile to Comparative Ex. 2. Niacinamide penetration was slow and very limited. In Comparative Ex. 3, penetration was initially higher and then reached a plateau. None of the Comparative Examples contained a polyglyceryl ester of fatty acid with an HLB of about 8 to about 20.

[0297] However, Inventive Example 1 showed that the penetration of niacinamide was about 78% at the beginning, which was much higher than for any of the Comp. Examples. Thereafter, the penetration continued to increase and was above 80% after only a few hours. The penetration level was stable after 24 hours. The Inventive Example proved that the presence of a polyglyceryl ester of fatty acid having an HLB of about 8 to about 20 not only increased the penetration level of the active ingredient, but surprisingly, did so almost immediately after the products were applied to the membrane.

[0298] These experiments surprisingly showed that the use of at least one fatty acid polyglyceryl ester influences the rate of penetration of an active ingredient through the membrane and simultaneously increased the % penetration through the membrane and potentially through human skin.

[0299] Comparison of the Inventive Ex. and Comparative Ex. 1, 2, 3, 4 as well as the Basic Formula surprisingly showed that the use of at least one fatty acid polyglyceryl ester amplified the penetration of THP compared to the case in which the fatty acid polyglyceryl ester is not present, even though the Comparative Examples contained known penetration enhancers, such as ethoxydiglycol, dimethyl isosorbide, sodium dilauramidoglutamide lysine. The penetration is better than with the known penetration enhancers.

[0300] Although the disclosure has been described with reference to described embodiments, it will be understood by those skilled in the art that various modifications may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. Furthermore, numerous modifications may be made to adapt a particular situation or subject matter to the teachings of the disclosure without departing from the essential scope thereof. Accordingly, it is intended that the disclosure not be limited to the embodiment particular disclosed as the best mode contemplated for carrying out this disclosure, but that the disclosure includes all embodiments falling within the scope of the invention.

[0301] The term "INCI" is an abbreviation for International Nomenclature of Cosmetic Ingredients, which is a system of names provided by the Personal Care Products Council's International Nomenclature Committee to describe the ingredients of personal care products.

[0302] “At least one” as used herein means one or several and thus includes individual components as well as mixtures / combinations.

[0303] The transitional terms "comprising," "consisting essentially of," and "consisting of," when used, in their original and modified forms, define the scope of the application with respect to additional unmentioned elements or steps, if any, which are excluded from the scope of the application. The term "comprising" is intended to be inclusive or broad and does not exclude any additional, unmentioned element, process, step, or material. The term "consisting of" excludes any element, step, or material other than those specified and, in the latter case, impurities ordinarily associated with the specified material(s). The term "consisting essentially of" limits the scope to the specified elements, steps, or materials and to those which do not materially affect the fundamental and novel feature(s) of the claimed disclosure.All materials and methods described herein that embody the present disclosure may, in other embodiments, be more specifically defined by any of the transitional terms "comprising", "consisting essentially of", and "consisting of".

[0304] The terms "free" and "devoid" indicate that no reliably measurable excluded material is present in the composition, typically 0% by weight, based on the total weight of the composition. The term "substantially free" means that, although it is preferable that no excluded material be present in the composition, it is possible to have very small amounts of the excluded material in the composition of the invention, provided that such amounts do not materially affect the advantageous properties of the composition. In particular, "substantially free" means that the excluded material may be present in the composition in an amount of less than about 0.1% by weight, based on the total weight of the composition.

[0305] All percentages and ratios are calculated by weight unless otherwise indicated. All percentages are calculated based on the total composition unless otherwise indicated. In general, unless expressly stated otherwise in the herein, "weight" or "amount" as used herein with respect to the percentage of an ingredient refers to the amount of raw material comprising the ingredient, where the raw material may be described herein as comprising less than and up to 100% of the ingredient's activity. Accordingly, the weight percentage of an active ingredient in a composition is represented as the amount of raw material containing the active ingredient that is used and may or may not reflect the final percentage of the active ingredient, where the final percentage of the active ingredient depends on the weight percentage of the active ingredient in the raw material.

[0306] The terms "weight percent" and "weight %" may be used interchangeably and mean the percentage by weight, based on the total weight of a composition, article, or material, except as may be specified with respect to, for example, a phase or system that is a component of a composition, article, or material. All ranges and amounts set forth herein are intended to include subranges and amounts using any disclosed point as a boundary. Thus, a range of "1% to 10%, such as 2% to 8%, such as 3% to 5%" is intended to encompass ranges of "1% to 8%," "1% to 5%," "2% to 10%," and so on. All figures, amounts, ranges, etc. are intended to be modified by the term "about," whether or not expressly stated.Similarly, a given range of "about 1% to 10%" is intended to have both its 1% and 10% limits modified by the term "about." Further, it is understood that where an amount of a component is given, it is intended to mean the amount of active ingredient unless expressly stated otherwise.

[0307] Although the numerical ranges and parameters defining the general scope of the disclosure are approximations, unless otherwise indicated, the numerical values ​​presented in the specific examples are reported as accurately as possible. However, any numerical value inherently contains certain errors necessarily resulting from the standard deviation observed in their respective test measurements. The following example serves to illustrate embodiments of the present disclosure without, however, being limiting in nature.

Claims

Claims

1. Oil-in-water cosmetic composition comprising: i. at least one compound selected from the compounds of formula (I) and the tautomer of formula (!) below or their salts; and their optical isomers, racemates, and / or solvates such as hydrates, alone or in mixture: Formulas (I) and (I') in which: -Ri denotes a radical chosen from: a) a hydrogen atom; b) a linear or branched C1-C10 saturated alkyl group optionally substituted by one or more groups, which may be identical or different, chosen from: i) -O-R3 ii) -S-R3; - R2 designates a radical chosen from: a) a hydrogen atom; b) a linear C1-C12 or branched C3-C12 or cyclic C3-C8 saturated hydrocarbon group, optionally substituted by one or more groups, which may be the same or different, chosen from: i) -O-R3 ii) -S-R3 iii) -C(O)-O-R3 ; iv) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals c) a C5-C12 aryl group, optionally substituted by one or more hydroxyls and / or by one or more CrC8 alkoxy radicals -R3 denotes a radical chosen from: a) a hydrogen atom; b) a linear or branched C1-C10 saturated alkyl group; i. one or more fatty acid polyglyceryl esters; ii. one or more oils; and wherein the oil-in-water cosmetic composition is a macroemulsion. wherein the weight percentages are based on the total weight of the cosmetic composition.

2. A composition according to claim 1, further comprising a nia-cinamide.

3. A composition according to any preceding claim, wherein the composition is in the form of an oil-in-water macroemulsion.

4. A composition according to any preceding claim, wherein the penetration of the thiopyridininone compound i) is enhanced by the use of one or more fatty acid polyglyceryl esters.

5. A composition according to any preceding claim, wherein the thiopyridininone compound i) is present from about 0.01 to about 10% by weight, relative to the total weight of the cosmetic composition.

6. A composition according to any preceding claim, wherein the one or more fatty acid polyglyceryl esters have an HLB of about 8 to about 20.

7. A composition according to any preceding claim, wherein the one or more fatty acid polyglyceryl esters are present from about 0.5 to about 3% by weight, based on the total weight of the cosmetic composition.

8. A composition according to any preceding claim, wherein the oily phase is present from about 2 to about 25% by weight, relative to the total weight of the cosmetic composition.

9. The composition of claim 1, wherein the pH is from about 4.5 to about 6.5, preferably from about 5 to about 6.

10. A method of using the cosmetic composition of claim 1, comprising applying the cosmetic composition of claim 1 to the surface of a skin, wherein the cosmetic composition of claim 1 enhances the penetration of the thiopyridinone compound i).